What the World IP Index Tells Us About America's Innovation Future: A Conversation with Ryan Denson at the U.S. Chamber of Commerce
October is Intellectual Property Month, a time to reflect on how IP protections have helped make the United States a global leader in the life sciences.
In recognition, We Work For Health's Executive Director Dan Leonard sat down with Ryan Denson, Senior Manager of IP Policy at the U.S. Chamber of Commerce, to discuss the state of global intellectual property protections and what's at stake for patients and American innovation leadership.
Earlier this year, the Chamber released its 14th Annual International IP Index, evaluating the IP systems of 55 economies that together represent 95% of global GDP.
The conversation provided a timely perspective on where the world of IP policy is headed and why it matters today.
Check out the highlights below.
IP is a Rising Tide That Lifts All Boats
Strong IP frameworks don't just benefit individual companies; they create the conditions for innovation to flourish across the entire economy. Ryan explains how the Index provides a roadmap for governments around the world, identifying problems and pointing toward proven solutions from global best practices.
A "Laboratory of Bad Ideas." How the EU is Moving in the Wrong Direction
One of the most alarming findings in this year's Index is the EU's General Pharmaceutical Legislation, which has weakened several long-standing IP protections in the bloc. The consequences could be severe: for patients, for investment and for the future of medical innovation. These changes were significant enough to lower the IP scores of multiple EU member states in this year's Index.
What makes the EU's policy shift particularly dangerous is the signal it sends beyond its own borders. For decades, the EU served as a gold standard for IP protection that other nations looked to and followed. That influence is now working in reverse, giving other economies cover to weaken their own standards.
Bright Spots: Emerging Markets are Getting it Right
There is reason for optimism. Even as some established markets weaken their IP frameworks, emerging economies around the world are moving in the right direction, recognizing that protecting intellectual property is not a barrier to economic development, but the engine of it.
Watch the full conversation with Ryan Denson to learn more about what global IP trends mean for life sciences innovation and what's at stake for American patients.